Complications from Fetal Macrosomia

A baby born weighing more than 8 pounds 13 ounces (or 4,000 grams) weighs significantly more than the average baby, and so meets the definition for macrosomia, or “big baby syndrome”, which carries with it the risk of injury during delivery.   If the baby’s birthweight…

Increasing Motorcycle Fatalities in Maryland

The Governors’ Highway Safety Association’s most recent report indicates that nearly 5,000 people are killed in motorcycle accidents each year.  Even with Maryland’s strict helmet laws, motorcyclists are still dying at a higher rate than other motorists. When a motorcycle rider does survive a crash,…

Dangerous carcinogens discovered in heart medication Valsartan

In July of 2018, concerns about cancer prompted the FDA (Food and Drug Administration) to issue a voluntary recall for the blood pressure and heart medication Valsartan. Doctors prescribe Valsartan for patients to treat their high blood pressure and congestive heart failure.  Pharmacies are sending…

Mirena – Much More Than A Headache

Bayer, a multibillion-dollar pharmaceutical company, and manufacturer of the Mirena intrauterine device (IUD), has a history of deceiving the public with regard to the safety of its products. In fact, in 2009, Bayer received two warnings from the FDA that its television and internet advertising…

Yost Legal Group Selects Recipient of 2018 College Essay Scholarship

As always, Yost Legal Group is thrilled by any opportunity to help students in our community succeed. This year, the Yost Legal Group 2018 College Scholarship Essay Program welcomed submissions from current or prospective undergraduate students attending accredited universities and colleges. This year’s recipient was…

Essure Litigation – Status Update

On July 20, 2018, Bayer issued a press release announcing that, as of December 2018, Essure would no longer be sold in the United States. To many, this decision seems long overdue, particularly in light of the fact that, since September of 2017, Bayer had…

Diabetes Drugs linked to Pancreatic Cancer Since 2013

In March of 2013, the U.S. Food and Drug Administration (FDA) issued a safety communication linking diabetes drugs known as Incretin Mimetics, which include the brands Januvia, Janumet, Byetta Onglyza and Victoza, to serious pancreatic diseases, including cancer.  These drugs work by imitating the incretin…